| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/25/2012 | EP2408762A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof |
| 01/25/2012 | EP2408761A1 Substituted indole derivatives and methods of use thereof |
| 01/25/2012 | EP2408752A1 Substituted pyrimidines for the treatment of cancer |
| 01/25/2012 | EP2408744A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 01/25/2012 | EP2408454A2 Novel anti-inflammatory agents |
| 01/25/2012 | EP2328890B1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 01/25/2012 | EP2114924B1 Co-crystals and pharmaceutical compositions comprising the same |
| 01/25/2012 | EP1988075B1 Pyrrole derivative or salt thereof |
| 01/25/2012 | EP1917259B1 Pyrazine kinase inhibitors |
| 01/25/2012 | EP1856063B1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 01/25/2012 | EP1660458B1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/25/2012 | EP1074543B1 Aminopiperidine derivatives as integrin alpha v beta 3 antagonists |
| 01/25/2012 | CN1960988B Compounds and compositions as protein kinase inhibitors |
| 01/25/2012 | CN1558759B 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 01/25/2012 | CN102333783A Pyrromethene-boron complex compounds and organic electro- luminescent elements using same |
| 01/25/2012 | CN102333776A Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 01/25/2012 | CN102333772A Anti-viral compounds |
| 01/25/2012 | CN102333771A Indole derivatives as crth2 receptor antagonists |
| 01/25/2012 | CN102333770A P38 map kinase inhibitors |
| 01/25/2012 | CN102333533A Substituted quinazoline compounds |
| 01/25/2012 | CN102329307A Benzimidazole acid derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension |
| 01/25/2012 | CN102329305A Tetrazolyl carboxylic acid derivative and application thereof in preparing drugs for preventing and/or treating hypertension |
| 01/25/2012 | CN102329304A Diazaspiro derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension |
| 01/25/2012 | CN102329303A Biphenyltetrazole derivative and application thereof to preparation of medicament for preventing and/or treating hypertension |
| 01/25/2012 | CN102329267A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/25/2012 | CN101993538B Triazole diamine-containing modified bismaleimide resin and preparation method thereof |
| 01/25/2012 | CN101611016B Talarazole metabolites |
| 01/25/2012 | CN101456841B Amide derivative and medicine |
| 01/24/2012 | US8101778 Five-membered heterocycles useful as serine protease inhibitors |
| 01/24/2012 | US8101754 e.g., 2-tert-Butyl-4-{4-[3-(4-methyl-5-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-propyl]-piperazin-1-yl}-6-(1-methylcyclopropyl)-pyrimidine hydrochloride; central nervous system disorders; schizophrenia; antidepressant, anxiolytic agent, cognition activator; Parkinson's and Alzheimer's diseases |
| 01/24/2012 | US8101731 Yellow anionic disazo dyes |
| 01/24/2012 | US8101643 Benzimidazole derivatives |
| 01/24/2012 | US8101637 Alkynyl derivatives as modulators of metatropic glutamate receptors |
| 01/24/2012 | US8101621 Aminopyridine derivatives having aurora a selective inhibitory action |
| 01/24/2012 | US8101618 1,4-substituted piperazine derivatives |
| 01/24/2012 | US8101615 Chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, heart failure |
| 01/24/2012 | US8101608 Compounds and compositions as protein kinase inhibitors |
| 01/24/2012 | US8101084 Perchlorate ion trapping agent |
| 01/24/2012 | CA2684447C Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/24/2012 | CA2670760C Naphthyridine compounds as inhibitors of akt activity |
| 01/24/2012 | CA2642211C 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 01/24/2012 | CA2621404C Novel heterobicyclic derivatives |
| 01/24/2012 | CA2528010C 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/19/2012 | WO2012009134A1 Crth2 modulators |
| 01/19/2012 | WO2012008478A1 P2x4 receptor antagonist |
| 01/19/2012 | WO2012007748A1 New crystalline forms of n-[2-[[(2,3-difluoropheny)methyl)thio]-6-{[(1r,2s)-2,3-dihydroxy-1- methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide |
| 01/19/2012 | WO2012007685A1 Molecules having combinable groups |
| 01/19/2012 | WO2012007451A1 Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol and lactic acid |
| 01/19/2012 | WO2012007409A1 N-substituted pyrrolidines |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2011138751A3 Heterocyclic derivatives as alk inhibitors |
| 01/19/2012 | WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011106650A3 Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
| 01/19/2012 | WO2011103289A3 Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| 01/19/2012 | WO2011102645A3 An improved process for preparing telmisartan |
| 01/19/2012 | US20120016449 Phototherapy devices and methods comprising substituted carbazole compounds |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015959 Heterocyclic compounds as autotaxin inhibitors |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015954 Therapeutic agents useful for treating pain |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015927 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120014914 Inhibitors of serine proteases, particularly hcv ns3-ns4a proteases |
| 01/19/2012 | CA2807354A1 P2x4 receptor antagonist |
| 01/19/2012 | CA2804162A1 New crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6-{[(1r,2s)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl}-1-azetidinesulfonamide |
| 01/18/2012 | EP2407467A1 Crystalline compound of1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol and lactic acid |
| 01/18/2012 | EP2407454A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
| 01/18/2012 | EP2407452A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 01/18/2012 | EP2407451A1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/18/2012 | EP2406264A2 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors |
| 01/18/2012 | EP2406262A1 Prodrug forms of kinase inhibitors and their use in therapy |
| 01/18/2012 | EP2406251A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406250A1 Inhibitors of akt activity |
| 01/18/2012 | EP2406247A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406240A2 Inhibitors of beta-secretase |
| 01/18/2012 | EP2406230A1 Substituted indazole amides and their use as glucokinase activators |
| 01/18/2012 | EP1992618B1 Polycyclic cinnamide derivative |
| 01/18/2012 | EP1893196B1 Diarylhydantoin compound |
| 01/18/2012 | EP1831202B1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 01/18/2012 | EP1713780B1 Novel inhibitors of glutaminyl cyclase |
| 01/18/2012 | EP1506196B1 Pyrazolopyrimidines as sodium channel inhibitors |
| 01/18/2012 | EP1256574B1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 01/18/2012 | CN102325766A Heteroaryl substituted pyridazinone derivatives |
| 01/18/2012 | CN102325765A Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
| 01/18/2012 | CN102325764A Pyrimidine indole derivatives for treating cancer |
| 01/18/2012 | CN102325753A Carbazole carboxamide compounds useful as kinase inhibitors |
| 01/18/2012 | CN102325752A Carbazole and carboline kinase inhibitors |
| 01/18/2012 | CN102321075A Preparation and bactericidal activity of 2-(1H-imidazole-1-yl)quinazoline derivatives |
| 01/18/2012 | CN102321074A Indole ring-substituted pyrazole hydrazide derivative and preparation method and application thereof |
| 01/18/2012 | CN102321024A Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 01/18/2012 | CN101786990B Compound having anti-itching activity |
| 01/17/2012 | US8097721 High stability polyionic liquid salts |
| 01/17/2012 | US8097619 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |